Carillon Tower Advisers’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $73.6M | Buy |
575,271
+350,125
| +156% | +$44.8M | 0.45% | 65 |
|
|
2020
Q3 | $25.3M | Sell |
225,146
-444,321
| -66% | -$50M | 0.34% | 96 |
|
|
2020
Q2 | $63.8M | Buy |
669,467
+233,843
| +54% | +$22.3M | 0.49% | 66 |
|
|
2020
Q1 | $36.6M | Sell |
435,624
-222,016
| -34% | -$18.7M | 0.36% | 95 |
|
|
2019
Q4 | $34.9M | Hold |
657,640
| – | – | 0.23% | 152 |
|
|
2019
Q3 | $26M | Hold |
657,640
| – | – | 0.18% | 202 |
|
|
2019
Q2 | $27M | Hold |
657,640
| – | – | 0.19% | 203 |
|
|
2019
Q1 | $30.6M | Hold |
657,640
| – | – | 0.22% | 172 |
|
|
2018
Q4 | $28.6M | Hold |
657,640
| – | – | 0.24% | 164 |
|
|
2018
Q3 | $37.6M | Hold |
657,640
| – | – | 0.27% | 148 |
|
|
2018
Q2 | $31.9M | Sell |
657,640
-285,204
| -30% | -$13.8M | 0.25% | 145 |
|
|
2018
Q1 | $36.9M | Hold |
942,844
| – | – | 0.29% | 113 |
|
|
2017
Q4 | $40K | Buy |
+942,844
| New | +$40K | 0.43% | 80 |
|